Origins of FL genes

Tier 1 FL genes

66 total

Gene Tier First FL evidence Other entities
ACTB 1 lohrDiscoveryPrioritizationSomatic2012a?,wienandGenomicAnalysesFlowsorted2019b?
ARID1A 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 1,2,rossiCodingGenomeSplenic2012c?,wienandGenomicAnalysesFlowsorted2019b?
ATP6AP1 1 Okosun et alokosunRecurrentMTORC1activatingRRAGC2016a?
ATP6V1B2 1 Okosun et alokosunRecurrentMTORC1activatingRRAGC2016a?
B2M 1 Morin et al3 4,reichelFlowSortingExome2015a?
BCL2 1 Morin et al3 5,sarkozyMutationalLandscapeGray2021a?,burkhardtClinicalRelevanceMolecular2022b?
BCL6 1 2,3
BCL7A 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 1,6,reichelFlowSortingExome2015a?
BIRC6 1 7,sarkozyMutationalLandscapeGray2021a?
BTG1 1 3,sarkozyMutationalLandscapeGray2021a?,burkhardtClinicalRelevanceMolecular2022b?
BTG2 1 Morin et al3 2
BTK 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? albuquerqueEnhancingKnowledgeDiscovery2017a?
CARD11 1 Morin et al3 8,9,yanBCRTLRSignaling2012a?
CCND3 1 Morin et al3 10,11,richterRecurrentMutationID32012a?
CD83 1 Russler et alrussler-germainMutationsAssociatedProgression2023b? 12,13,dunsCharacterizationDLBCLPMBL2021b?
CREBBP 1 Pasqualucci et alpasqualucciInactivatingMutationsAcetyltransferase2011a? 2,14,dunsCharacterizationDLBCLPMBL2021b?
CTSS 1 Bararia et albarariaCathepsinAlterationsInduce2020c?
DTX1 1 1,2,15,rossiCodingGenomeSplenic2012c?
EBF1 1 16,17,reichelFlowSortingExome2015a?
EEF1A1 1 Hubschmann et alhubschmannMutationalMechanismsShaping2021b? reichelFlowSortingExome2015a?
EP300 1 Pasqualucci et alpasqualucciInactivatingMutationsAcetyltransferase2011a? rossiCodingGenomeSplenic2012c?
EZH2 1 Morin et almorinSomaticMutationsAltering2010a? 2,mottokIntegrativeGenomicAnalysis2019b?
FAS 1 18,spinaGeneticsNodalMarginal2016b?
FOXO1 1 Morin et al3 19,dunsCharacterizationDLBCLPMBL2021b?
GNA13 1 Morin et al3 2,reichelFlowSortingExome2015a?
GNAI2 1 6,12
HIST1H1B 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? sarkozyMutationalLandscapeGray2021a?,chapuyMolecularSubtypesDiffuse2018b?
HIST1H1C 1 Morin et al3 13
HIST1H1D 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 10,12
HIST1H1E 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 6,reichelFlowSortingExome2015a?,lohrDiscoveryPrioritizationSomatic2012a?
HIST1H2AC 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 12
HIST1H2AG 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 12,13,rossiCodingGenomeSplenic2012c?
HIST1H2AM 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 13,chapuyMolecularSubtypesDiffuse2018b?
HIST1H2BC 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? lohrDiscoveryPrioritizationSomatic2012a?,mottokIntegrativeGenomicAnalysis2019b?
HIST1H2BD 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b?
HIST1H2BG 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b?
HIST1H3B 1 reichelFlowSortingExome2015a?,lohrDiscoveryPrioritizationSomatic2012a?
HIST1H3G 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b?
HVCN1 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? chapuyMolecularSubtypesDiffuse2018b?
IRF4 1 3,mottokIntegrativeGenomicAnalysis2019b?
IRF8 1 Morin et al3 13,mottokIntegrativeGenomicAnalysis2019b?
ITPKB 1 schmitzGeneticsPathogenesisDiffuse2018a?,reichelFlowSortingExome2015a?
KLF2 1 10,11,20
KLHL6 1 Morin et al3 21
KMT2D 1 Morin et al3 6,11,22,rossiCodingGenomeSplenic2012c?
LTB 1 11,chapuyMolecularSubtypesDiffuse2018b?
MAP2K1 1 Louissaint et allouissaintPediatrictypeNodalFollicular2016a? 23
MEF2B 1 Morin et al3 22
MEF2C 1 24
PCLO 1 lohrDiscoveryPrioritizationSomatic2012a?
PIM1 1 dunsCharacterizationDLBCLPMBL2021b?,pasqualucciHypermutationMultipleProtooncogenes2001a?,burkhardtClinicalRelevanceMolecular2022b?
POU2AF1 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? chapuyMolecularSubtypesDiffuse2018b?
POU2F2 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? lohrDiscoveryPrioritizationSomatic2012a?
PTPRD 1 spinaGeneticsNodalMarginal2016b?
RRAGC 1 okosunRecurrentMTORC1activatingRRAGC2016a?
S1PR2 1 3,muppidiLossSignalingGa132014b?
SGK1 1 Morin et al3 dunsCharacterizationDLBCLPMBL2021b?
SMARCA4 1 Krysiak et alkrysiakRecurrentSomaticMutations2017b? richterRecurrentMutationID32012a?,lohrDiscoveryPrioritizationSomatic2012a?,nadeuGenomicEpigenomicInsights2020b?
SOCS1 1 3,wenigerMutationsTumorSuppressor2006a?
STAT6 1 Yildiz et alyildizActivatingSTAT6Mutations2015c? ritzRecurrentMutationsSTAT62009a?
TBL1XR1 1 lohrDiscoveryPrioritizationSomatic2012a?,rossiCodingGenomeSplenic2012c?
TMSB4X 1 albuquerqueEnhancingKnowledgeDiscovery2017a?
TNFAIP3 1 rossiAlterationBIRC3Multiple2011a?,compagnoMutationsMultipleGenes2009a?,schmitzTNFAIP3A20Tumor2009a?
TNFRSF14 1 Cheung et alcheungAcquiredTNFRSF14Mutations2010a? 3,spinaGeneticsNodalMarginal2016b?
TP53 1 Morin et al3 22,25,lohrDiscoveryPrioritizationSomatic2012a?,rossiCodingGenomeSplenic2012c?,tiacciPervasiveMutationsJAKSTAT2018b?
VMA21 1 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?

Tier 2 FL genes

49 total

Gene Tier First FL evidence Other entities
ABL2 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
ACTG1 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b? 11,spinaGeneticsNodalMarginal2016b?
ATP6V1A 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
BCL10 2 Russler et alrussler-germainMutationsAssociatedProgression2023b? 3,spinaGeneticsNodalMarginal2016b?
CD70 2 Russler et alrussler-germainMutationsAssociatedProgression2023b? 3
CD79B 2 3,13
CDC42BPB 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b? spinaGeneticsNodalMarginal2016b?
CILP 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
CPNE8 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
CXCR4 2 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 13,26
CYP2A6 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
DDX3X 2 7,19,mottokIntegrativeGenomicAnalysis2019b?
DHX15 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
DUSP2 2 dunsCharacterizationDLBCLPMBL2021b?,lohrDiscoveryPrioritizationSomatic2012a?
EGR1 2 Krysiak et alkrysiakRecurrentSomaticMutations2017b? reichelFlowSortingExome2015a?,rossiCodingGenomeSplenic2012c?
FZR1 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
GBP7 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
GRM6 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
HIST1H2BM 2 Krysiak et alkrysiakRecurrentSomaticMutations2017b?
HIST1H3I 2 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 13
HLA-B 2 wienandGenomicAnalysesFlowsorted2019b?,lohrDiscoveryPrioritizationSomatic2012a?
HNRNPD 2 7
IGLL5 2 Russler et alrussler-germainMutationsAssociatedProgression2023b? 11,13,chapuyMolecularSubtypesDiffuse2018b?
JUP 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
KIR3DL1 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
LAPTM5 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
MAGEC1 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
MAP7D1 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
MGEA5 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
MKI67 2 Russler et alrussler-germainMutationsAssociatedProgression2023b? 19
MYC 2 10,27,dunsCharacterizationDLBCLPMBL2021b?,pasqualucciHypermutationMultipleProtooncogenes2001a?
MYCBP2 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
MYD88 2 ngoOncogenicallyActiveMYD882011a?,yanBCRTLRSignaling2012a?
NFKBIA 2 Russler et alrussler-germainMutationsAssociatedProgression2023b? 28,wienandGenomicAnalysesFlowsorted2019b?
OR8H2 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
P2RY8 2 muppidiLossSignalingGa132014b?,lohrDiscoveryPrioritizationSomatic2012a?
PDS5B 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b? 12
PPP4C 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
PRKDC 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b? schmitzGeneticsPathogenesisDiffuse2018a?
PZP 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
RBM6 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
SHROOM3 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
SRRM2 2 Russler et alrussler-germainMutationsAssociatedProgression2023b? 12
STAB2 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
TMEM30A 2 Morin et al3
TPP1 2 Hubschmann et alhubschmannMutationalMechanismsShaping2021b?
XIRP2 2 Russler et alrussler-germainMutationsAssociatedProgression2023b?
ZC3H12A 2 24
ZNF608 2 Krysiak et alkrysiakRecurrentSomaticMutations2017b? 1

Tier 3 FL genes

0 total

Gene Tier First FL evidence Other entities

References

1.
Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:1398–1403. PMCID: PMC3557051
2.
Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
3.
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJM, Connors JM, Hirst M, Gascoyne RD, Marra MA. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011 Jul 27;476(7360):298–303. PMCID: PMC3210554
4.
Pararajalingam P, Coyle KM, Arthur SE, Thomas N, Alcaide M, Meissner B, Boyle M, Qureshi Q, Grande BM, Rushton C, Slack GW, Mungall AJ, Tam CS, Agarwal R, Dawson SJ, Lenz G, Balasubramanian S, Gascoyne RD, Steidl C, Connors J, Villa D, Audas TE, Marra MA, Johnson NA, Scott DW, Morin RD. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. 2020 Jul 30;136(5):572–584. PMCID: PMC7440974
5.
Tanaka S, Louie DC, Kant JA, Reed JC. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin’s lymphomas. Blood. 1992 Jan 1;79(1):229–237.
6.
Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE, Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG, Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J, Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH, Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019;133(12):1313–1324. PMCID: PMC6428665
7.
Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017 Oct;171(2):481–494.e15. PMCID: PMC5659841
8.
Wu C, de Miranda NF, Chen L, Wasik AM, Mansouri L, Jurczak W, Galazka K, Dlugosz-Danecka M, Machaczka M, Zhang H, Peng R, Morin RD, Rosenquist R, Sander B, Pan-Hammarström Q. Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations. Oncotarget. 2016 Jun 21;7(25):38180–38190. PMCID: PMC5122381
9.
Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008 Mar;319(5870):1676–1679.
10.
Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A. Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica. 2017 Oct;102(10):1758–1766. PMCID: PMC5622860
11.
Desch AK, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF, Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW, Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A, Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. Leukemia. 2020 Jan;34(1):151–166.
12.
Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC, Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A, Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL, Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood. 2013 Aug 15;122(7):1256–1265. PMCID: PMC3744992
13.
Panea R, Love C, Shingleton JR, Reddy A, Bailey J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N, Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S, Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome landscape of Burkitt lymphoma subtypes. Blood. 2019;
14.
Parry M, Rose-Zerilli MJJ, Gibson J, Ennis S, Walewska R, Forster J, Parker H, Davis Z, Gardiner A, Collins A, Oscier DG, Strefford JC. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. PLoS One. 2013;8(12):e83244. PMCID: PMC3862727
15.
Gomez F, Fisk B, McMichael JF, Mosior M, Foltz JA, Skidmore ZL, Duncavage EJ, Miller CA, Abel H, Li YS, Russler-Germain DA, Krysiak K, Watkins MP, Ramirez CA, Schmidt A, Martins Rodrigues F, Trani L, Khanna A, Wagner JA, Fulton RS, Fronick CC, O’Laughlin MD, Schappe T, Cashen AF, Mehta-Shah N, Kahl BS, Walker J, Bartlett NL, Griffith M, Fehniger TA, Griffith OL. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. Cancer Res Commun. 2023 Nov 15;3(11):2312–2330. PMCID: PMC10648575
16.
Bohle V, Döring C, Hansmann M-L, Küppers R. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma. Leukemia. 2013 Mar;27(3):671–679.
17.
Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, Barta S, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Chadburn A, Cruz M, Dittmer DP, Dyer MA, Farinha P, Gastier-Foster JM, Gerrie AS, Grande BM, Greiner T, Griner NB, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi R, Leal FE, Lee MS, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack G, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson WH, Wong J, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Morin RD. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023 Feb 23;141(8):904–916. PMCID: PMC10023728
18.
Scholl V, Stefanoff CG, Hassan R, Spector N, Renault IZ. Mutations within the 5’ region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma. Leuk Lymphoma. 2007 May;48(5):957–963.
19.
Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012 Oct 4;490(7418):116–120. PMCID: PMC3609867
20.
Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera R. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet. 2011 Jul 31;43(9):830–837. PMCID: PMC3297422
21.
Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, Nahum O, Levy B, Xie Y, Khattar P, Hoehn D, Bertoni F, Murty VV, Pittaluga S, Jaffe ES, Alobeid B, Mansukhani MM, Bhagat G. The genetic landscape of dural marginal zone lymphomas. Oncotarget. Impact Journals; 2016 May 27;7(28):43052–43061.
22.
Beà S, Valdés-Mas R, Navarro A, Salaverria I, Martín-Garcia D, Jares P, Giné E, Pinyol M, Royo C, Nadeu F, Conde L, Juan M, Clot G, Vizán P, Croce LD, Puente DA, López-Guerra M, Moros A, Roue G, Aymerich M, Villamor N, Colomo L, Martínez A, Valera A, Martín-Subero JI, Amador V, Hernández L, Rozman M, Enjuanes A, Forcada P, Muntañola A, Hartmann EM, Calasanz MJ, Rosenwald A, Ott G, Hernández-Rivas JM, Klapper W, Siebert R, Wiestner A, Wilson WH, Colomer D, López-Guillermo A, López-Otín C, Puente XS, Campo E. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. PNAS. 2013;110(45):18250–18255.
23.
Shin SY, Lee ST, Kim HJ, Ki CS, Jung CW, Kim JW, Kim SH. BRAF V600E and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone lymphoma cases. Ann Lab Med. 2015 Mar;35(2):257–259. PMCID: PMC4330180
24.
Arthur SE, Jiang A, Grande BM, Alcaide M, Cojocaru R, Rushton CK, Mottok A, Hilton LK, Lat PK, Zhao EY, Culibrk L, Ennishi D, Jessa S, Chong L, Thomas N, Pararajalingam P, Meissner B, Boyle M, Davidson J, Bushell KR, Lai D, Farinha P, Slack GW, Morin GB, Shah S, Sen D, Jones SJM, Mungall AJ, Gascoyne RD, Audas TE, Unrau P, Marra MA, Connors JM, Steidl C, Scott DW, Morin RD. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat Commun. 2018 Oct 1;9(1):4001. PMCID: PMC6167379
25.
Wilda M, Bruch J, Harder L, Rawer D, Reiter A, Borkhardt A, Woessmann W. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt’s lymphoma in children. Leukemia. 2004 Mar;18(3):584–588.
26.
Khodabakhshi AH, Morin RD, Fejes AP, Mungall AJ, Mungall KL, Bolger-Munro M, Johnson NA, Connors JM, Gascoyne RD, Marra MA, Birol I, Jones SJM. Recurrent targets of aberrant somatic hypermutation in lymphoma. Oncotarget. 2012;3(11):1308–1319. PMCID: PMC3717795
27.
Johnston JM, Carroll WL. C-myc hypermutation in Burkitt’s lymphoma. Leuk Lymphoma. 1992 Dec;8(6):431–439.
28.
Lake A, Shield LA, Cordano P, Chui DTY, Osborne J, Crae S, Wilson KS, Tosi S, Knight SJL, Gesk S, Siebert R, Hay RT, Jarrett RF. Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases. Int J Cancer. 2009 Sep 15;125(6):1334–1342.